These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 9244387)

  • 1. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
    Keck RG; Berleau L; Harris R; Keyt BA
    Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
    Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation pattern and disulfide assignments of recombinant human differentiation-stimulating factor.
    Schmelzer CH; Harris RJ; Butler D; Yedinak CM; Wagner KL; Burton LE
    Arch Biochem Biophys; 1993 May; 302(2):484-9. PubMed ID: 8489250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry.
    Hoffman RC; Jennings LL; Tsigelny I; Comoletti D; Flynn RE; Sudhof TC; Taylor P
    Biochemistry; 2004 Feb; 43(6):1496-506. PubMed ID: 14769026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of tumor necrosis factor binding protein disulfide structure: deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature.
    Jones MD; Hunt J; Liu JL; Patterson SD; Kohno T; Lu HS
    Biochemistry; 1997 Dec; 36(48):14914-23. PubMed ID: 9398215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
    Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
    J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6.
    Neumann GM; Marinaro JA; Bach LA
    Biochemistry; 1998 May; 37(18):6572-85. PubMed ID: 9572875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
    Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
    Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human keratinocyte growth factor recombinantly expressed in Chinese hamster ovary cells: isolation of isoforms and characterization of post-translational modifications.
    Hsu YR; Hsu EW; Katta V; Brankow D; Tseng J; Hu S; Morris CF; Kenney WC; Lu HS
    Protein Expr Purif; 1998 Mar; 12(2):189-200. PubMed ID: 9518460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfide structure and N-glycosylation sites of an extracellular domain of granulocyte-colony stimulating factor receptor.
    Haniu M; Horan T; Arakawa T; Le J; Katta V; Hara S; Rohde MF
    Biochemistry; 1996 Oct; 35(40):13040-6. PubMed ID: 8855939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, primary structure characterization and identification of the glycosylation pattern of recombinant goldfish neurolin, a neuronal cell adhesion protein.
    Denzinger T; Diekmann H; Bruns K; Laessing U; Stuermer CA; Przybylski M
    J Mass Spectrom; 1999 Apr; 34(4):435-46. PubMed ID: 10226368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli.
    Merewether LA; Le J; Jones MD; Lee R; Shimamoto G; Lu HS
    Arch Biochem Biophys; 2000 Mar; 375(1):101-10. PubMed ID: 10683254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular domain of neurotrophin receptor trkB: disulfide structure, N-glycosylation sites, and ligand binding.
    Haniu M; Talvenheimo J; Le J; Katta V; Welcher A; Rohde MF
    Arch Biochem Biophys; 1995 Sep; 322(1):256-64. PubMed ID: 7574684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human brain-derived neurotrophic factor (rHuBDNF). Disulfide structure and characterization of BDNF expressed in CHO cells.
    Acklin C; Stoney K; Rosenfeld RA; Miller JA; Rohde MF; Haniu M
    Int J Pept Protein Res; 1993 Jun; 41(6):548-52. PubMed ID: 8349412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
    Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of recombinant human carboxy-terminal-truncated macrophage colony-stimulating factor.
    Yamanishi K; Randawa ZI; Brown D; Masui Y; Yasuda S; Takahashi M; Adachi M
    J Biochem; 1993 Jan; 113(1):81-7. PubMed ID: 8454579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic fragmentation reveals the oligomeric and domain structure of porcine aminopeptidase A.
    Hesp JR; Hooper NM
    Biochemistry; 1997 Mar; 36(10):3000-7. PubMed ID: 9062131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization of the receptor binding domain of vascular endothelial growth factor.
    Christinger HW; Muller YA; Berleau LT; Keyt BA; Cunningham BC; Ferrara N; de Vos AM
    Proteins; 1996 Nov; 26(3):353-7. PubMed ID: 8953654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
    Yamazaki Y; Tokunaga Y; Takani K; Morita T
    Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.